Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Padmakar Gandla
Institution:
Catalent (United States)
Observed institution:
Catalent (United States)
ORCID:
0009-0003-6175-8958
Observed ORCID:
0009-0003-6175-8958
OpenAlex ID:
A5139664721
Particle Morphology as a Critical Material Attribute in Pharmaceutical Development: Characterization, Quality Impact, and Control Strategies
2026
·
Murugesan Palanivelu
, Jayaram Kamma
, et al.
·
American Journal of Analytical Chemistry
·
1
PDF
Implementation Science in the Pharmaceutical Industry: Why we Know which Innovations Work but Still Cannot Implement Them - A Comparative Review of the United States, the European Union, and International Regulatory Contexts
2026
·
Murugesan Palanivelu
, Prabakaran Ramachandran
, et al.
·
Saudi Journal of Medical and Pharmaceutical Sciences
PDF
Forced Degradation Profiling and Putative Structural Characterization of Atogepant Degradation Products by LC‐QTOF‐MS/MS Supported by In‐Silico Degradation‐Pathway and Toxicity Assessments
2026
·
Jayaram Kamma
, Murugesan Palanivelu
, et al.
·
Separation Science Plus
PDF
A Green Analytical Stability Indicating RP HPLC Method for Determination of Related Impurities in Istradefylline Dosage Forms. Robustness Study by Quality by Design Approach
2026
·
Venkatanarayana Bypaneni
, Padmakar Gandla
, et al.
·
Saudi Journal of Medical and Pharmaceutical Sciences
PDF
Show more works
View as search
Works count:
4
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type